FSFWX | RSLDX | FSFWX / RSLDX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 4 years | 9 years | - |
Gain YTD | 7.212 | 7.125 | 101% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 77.1B | 77.1B | 100% |
Annual Yield % from dividends | 0.90 | 0.83 | 109% |
Returns for 1 year | 22.98 | 22.85 | 101% |
Returns for 3 years | -20.24 | -20.55 | 99% |
Returns for 5 years | N/A | 28.94 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DVLCX | 25.77 | 0.25 | +0.98% |
BNY Mellon Opportunistic Midcap Value C | |||
SMLPX | 9.90 | 0.06 | +0.61% |
Westwood Salient MLP & Engy Infras Inst | |||
RYOIX | 80.61 | 0.43 | +0.54% |
Rydex Biotechnology Inv | |||
JANWX | 117.72 | 0.59 | +0.50% |
Janus Henderson Global Research D | |||
FCNKX | 21.58 | 0.08 | +0.37% |
Fidelity Contrafund K |